At study entry, patients demonstrated immune compromise consistent with prior standard of care, including radiation and alkylating chemotherapy. The baseline mean absolute lymphocyte count (ALC) was ...

Haggis is, of course, a central part of celebrating Burns Night (January 25). As a Scot, I’ve seen my fair share of this dish ...

ImmunityBio, Inc. , a commercial-stage immunotherapy company developing cytokine and cellular immunotherapies designed to ...

Dr. Ian Flinn explains in an interview with CURE how Lunsumio VELO (mosunetuzumab) works and its impact on patients with ...

As new research suggests that inflammation isn’t just caused by age, but by our lifestyles and environments, Harry Bullmore ...

The surprising new research behind what actually causes high blood pressure – and the best ways to keep yours in check ...

This encyclopedic article outlines evidence-based laboratory tests that are most useful for establishing individualized ...

Cellectis (the 'Company”) (Euronext Growth: ALCLS - NASDAQ: CLLS), a clinical-stage biotechnology company using its ...

As of Monday, January 05, Zenas BioPharma, Inc.’s ZBIO share price has dipped by 55.44%, which has investors questioning if this is right time to buy.

A study in Ladakh shows soldiers from the plains face higher rates of acne, alopecia, and eczema than natives. Harsh UV and cold stress drive these skin issues, requiring better protective care.

Retained products of conception (RPOC) is a condition where some remnants of trophoblast or placenta are retained after ...

Existing treatments for other conditions show potential for use in managing type 1 diabetes, a recent scientific conference heard ...